Spatiotemporal tSCS in Spinal Cord Injury

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-65
SponsorWashington University School of Medicine

About this trial

Spinal cord injury leads to long-lasting impairment, and currently, there is no cure for paralysis. Although transcutaneous spinal cord stimulation has shown promising results in recovering lost movements, its poor selectivity in muscle recruitment compared to invasive approaches limits the type of rehabilitation exercises that can be practiced. This project studies how spatial, frequency, and amplitude control of stimulation can be used to selectively target different neural pathways and muscle groups.

Eligibility criteria

Qualifiers

Age between 16 and 65 years.

Have a spinal cord injury (neurological level C3-T12) that occurred ≥1 year (chronic stage) prior to enrollment.

American Spinal Injury Association (ASIA) Impairment Scale (AIS) classification C or D

Able to voluntarily contract (motor score ≥ 1) at least two leg muscles (visual or palpable contraction).

Disqualifiers

Progressive spinal lesions, including degenerative disorders of the spinal cord

Pregnant, planning to become pregnant, or currently breastfeeding

History of cardiopulmonary disease or cardiac symptoms

Implanted stimulators of any type (baclofen pump, epidural spinal stimulator, cardiac defibrillator, pace-maker, etc.)

Trial design

Treatments tested in this trial

  • No Stimulation
  • Conventional tSCS
  • Spatiotemporal tSCS

Treatment groups

48 Participants
are divided into 3 treatment groups